These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10495007)
1. Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on the neophobia-reducing properties of melatonin in BALB/c mice. Kopp C; Vogel E; Rettori MC; Delagrange P; Renard P; Lesieur D; Misslin R Pharmacol Biochem Behav; 1999 Sep; 64(1):131-6. PubMed ID: 10495007 [TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness. Kopp C; Vogel E; Rettori M; Delagrange P; Misslin R Neuropharmacology; 2000 Jul; 39(10):1865-71. PubMed ID: 10884567 [TBL] [Abstract][Full Text] [Related]
3. Effects of melatonin on neophobic responses in different strains of mice. Kopp C; Vogel E; Rettori MC; Delagrange P; Guardiola-Lemaître B; Misslin R Pharmacol Biochem Behav; 1999 Aug; 63(4):521-6. PubMed ID: 10462179 [TBL] [Abstract][Full Text] [Related]
4. Regulation of emotional behaviour by day length in mice: implication of melatonin. Kopp C; Vogel E; Rettori MC; Delagrange P; Renard P; Lesieur D; Misslin R Behav Pharmacol; 1999 Dec; 10(8):747-52. PubMed ID: 10780290 [TBL] [Abstract][Full Text] [Related]
5. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Belzung C; Berton F Behav Pharmacol; 1997 Nov; 8(6-7):541-8. PubMed ID: 9832968 [TBL] [Abstract][Full Text] [Related]
6. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277 [TBL] [Abstract][Full Text] [Related]
9. Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors. Pierrefiche G; Zerbib R; Laborit H Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):131-42. PubMed ID: 7905658 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands. Mor M; Spadoni G; Di Giacomo B; Diamantini G; Bedini A; Tarzia G; Plazzi PV; Rivara S; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM Bioorg Med Chem; 2001 Apr; 9(4):1045-57. PubMed ID: 11354661 [TBL] [Abstract][Full Text] [Related]
11. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661 [TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effects of a new 1-N substituted analog of melatonin in pinealectomized rats. Bustamante-García R; Lira-Rocha AS; Espejo-González O; Gómez-Martínez AE; Picazo O Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():133-9. PubMed ID: 24495777 [TBL] [Abstract][Full Text] [Related]
13. Involvement of the mt1 melatonin receptor in human breast cancer. Ram PT; Dai J; Yuan L; Dong C; Kiefer TL; Lai L; Hill SM Cancer Lett; 2002 May; 179(2):141-50. PubMed ID: 11888668 [TBL] [Abstract][Full Text] [Related]
14. Reentrainment of the spontaneous locomotor activity rhythm to a daylight reversal in C57BL/6 and C3H/He mice: implication of melatonin. Kopp C; Vogel E; Rettori MC; Delagrange P; Misslin R Physiol Behav; 2000 Jul 1-15; 70(1-2):171-6. PubMed ID: 10978493 [TBL] [Abstract][Full Text] [Related]
15. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Drazen DL; Nelson RJ Neuroendocrinology; 2001 Sep; 74(3):178-84. PubMed ID: 11528219 [TBL] [Abstract][Full Text] [Related]
16. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors. Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236 [TBL] [Abstract][Full Text] [Related]
17. Role of the MT Liu J; Clough SJ; Dubocovich ML Genes Brain Behav; 2017 Jun; 16(5):546-553. PubMed ID: 28160436 [TBL] [Abstract][Full Text] [Related]
18. Methods for the evaluation of drug action at the human melatonin receptor subtypes. Nonno R; Fraschini F; Stankov BM Biol Signals Recept; 1999; 8(1-2):32-40. PubMed ID: 10085460 [TBL] [Abstract][Full Text] [Related]
19. PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice. Belzung C; Pineau N; Beuzen A; Misslin R Pharmacol Biochem Behav; 1994 Oct; 49(2):433-6. PubMed ID: 7824561 [TBL] [Abstract][Full Text] [Related]
20. The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Griebel G; Belzung C; Misslin R; Vogel E Behav Pharmacol; 1993 Dec; 4(6):637-644. PubMed ID: 11224232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]